Viewing Study NCT01091259

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2026-06-03 @ 5:04 PM
Study NCT ID: NCT01091259
Status: COMPLETED
Last Update Posted: 2015-11-24
First Post: 2010-03-19
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
Sponsor: NYU Langone Health
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Fallopian Tube Cancer View
None Primary Peritoneal Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None antibody therapy View
None chemotherapy View
None biologic therapy View
None combination therapy View